Answers are grounded in this paper and cite their sources.
Explores collaboration outcomes in brands, indicating ontology match matters more than reach.
Brand-creator and brand-brand collaborations are routinely evaluated on reach - follower count, audience size,media value - while the practitioner literature on why some well-funded, well-targeted collaborations still fail toconvert remains thin. This paper proposes that collaboration outcomes are bounded not by reach but by ontologycongruence: the degree to which a partner's lifestyle identity, values, and audience self-concept match the brand'sown positioning, independent of audience size. Drawing on self-congruity theory (Sirgy, 1982) and thecelebrity-product match-up hypothesis (Kamins, 1990), the paper develops a two-dimensional framework audience overlap × ontology congruence - and tests it against six publicly documented 2026 collaborationsspanning three firm-size tiers: enterprise/celebrity-scale (Breanna Stewart × CLIF Bar, Zara × John Galliano,WHOOP × Cristiano Ronaldo, Target × Jay-Z), venture-backed mid-size (OLIPOP's creator program), andmicro-business. At the enterprise tier, fit is constructed through data-driven narrative and, when absent, producesmeasurable public tension rather than outright commercial failure. At the mid-size tier, fit is directly observable inperformance metrics: OLIPOP's creator-driven revenue share grew alongside a compositional shift towardsmaller, closer-fit creators (micro-influencers rising from 3% to approximately 20% of creator-attributed sales). Atthe micro-business tier, no comparably documented, named 2026 case could be located in public reporting - agap the paper treats as a finding in its own right, consistent with a proximity effect in which fit failures are caughtand corrected locally, before they generate the institutional visibility (press, investor disclosure) that producescitable cases at all. We conclude that the underlying mechanism - ontology congruence predicting collaborationdurability - does not change across scale, but its observability to outside researchers does, with direct implicationsfor how practitioners at each tier should evidence their own fit decisions.
No takes yet. Share an insight, caveat, or question.
Maria Emelianova (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: